United Therapeutics
NOTES: United Therapeutics: Flesh, Fiction, and the 47-Day Vending Machine
Marcus on United Therapeutics: the spin vs the invoice.
United Therapeutics
Marcus on United Therapeutics: the spin vs the invoice.
United Therapeutics
Forensic audit of United Therapeutics under Synthetic Organo.
United Therapeutics
File open 09 August 2026: United Therapeutics / Synthetic Organo.
Cassandra Protocol
The archive unlocks on 06 August 2026. File S01E03 pulls the clinical data on BioAge Labs and the quiet math of human longevity. Marcus and Katie audit the biological debt of aging in a world desperate to buy more time.
Biotech Investing
BioAge Labs is running a biological grift. They are refinancing the Hayflick limit with a glorified anti-inflammatory while ignoring the compounding debt of cellular aging. A forensic look at their massive burn rate and missing Phase 3 capital.
Cassandra Protocol
August 05, 2026: The archive opens on a $4.4 billion pivot from electricity to illumination. Are data centers trading one thermodynamic nightmare for another?
Tech-Fail
Lightmatter is a $4.4B unicorn with a leaky radiator. Pumping liquid into the most expensive silicon on Earth isn't innovation, it's a white flag.
Tech-Fail
A robot doing Olympic gymnastics just failed to pour coffee. Why Boston Dynamics built a backflipping, billion-dollar intern the market can't afford.
Fitness Culture
Your 'Beast Mode' playlist isn't music; it's a biological ransom note in Aggressive Phonk. Stop twitching and face the silence of the squat rack.
Tech-Fail
Synthetic organs aren't a cure; they're a biological payday loan. From $2 million ears to pig lungs, welcome to the two-tier abattoir of organ arbitrage.
Tech bubble
Ayar Labs is pitching a pristine glass highway, but it’s just the tech sector's most expensive banana stand. We unpack the great photonics meltdown.
Tech Fail
Tesla's $25 trillion humanoid robot dream is a Bluth family banana stand. Inside the high-tech/low-life decay of snapping tendons and VR puppeteers.